Space Industry and Business News  
EPIDEMICS
Erdogan gets jab as Turkey unrolls Chinese vaccine
By Burcin Gercek and Ozan Kose in Istanbul
Ankara Jan 14, 2021

Turkish President Recep Tayyip Erdogan stripped down to a black t-shirt and got vaccinated on Thursday as the nation of 83 million people began rolling out China's Sinovac jab despite conflicting data about its efficacy. The 66-year-old Turkish leader was whisked into an Ankara hospital by a bevy of security guards before emerging about an hour later to stress the importance of officials setting a good example by getting the jab. "There are some people doing negative campaigning (about vaccinations) but I am sure common sense will prevail," Erdogan said as a masked doctor stabbed him with a needle while a nurse put a comforting arm on his shoulder. "I believe it will be vital for political leaders and deputies to encourage the vaccination drive (by getting vaccinated) themselves," he later told a group of waiting reporters. One opinion poll conducted in November showed about half of Turkish respondents unwilling to take the jab. Health officials have spent two weeks testing the safety of the doses delivered from China after preliminary studies involving 7,371 volunteers in Turkey showed Sinovac's vaccine to be 91.25 percent effective. But a bigger trial in Brazil put the efficacy of Sinovac at 50.4 percent while a third one in Indonesia resulted in a 65.3 percent success rate, raising concerns about the Chinese manufacturer's transparency. Turkish television was plastered with images on Thursday of healthcare workers receiving their first doses as officials tried to raise awareness and acceptance of the vaccine. "Our citizens should not worry," Recep Demirhan, chief physician at a city hospital on the Asian side of Istanbul, told reporters as he received his shot, adding all vaccines arriving in Turkey are safe. And the doctors and nurses lining up for their shots sounded relieved after a year fighting a virus that has officially killed more than 23,000 in Turkey and filled hospitals in hotspots such as Ankara to capacity. "We have been struggling for a long time," said Nimet Aktasa, a health worker in Ankara. - 'Light at end of tunnel'- After covering Turkey's 1.1 million healthcare workers, the vaccination programme will move on to essential workers and people aged 65 and above. "This vaccination drive is needed to return to our normal, old way of life," Koca said on Wednesday. "We see the light at the end of the tunnel and I believe the coming days will be bright." Turkey has signed up for 50 million doses of CoronaVac. Twenty million of them are due to arrive by the end of the month. The official Anadolu news agency reported that Turkey also sent 20,000 doses to the breakaway state of northern Cyprus, which is recognised only by Ankara. In December, Turkey also reached a deal to receive 4.5 million doses of the Pfizer-BioNTech jab by late March. Officials hope to receive up to 30 million doses from Pfizer-BioNTech, although talks are still ongoing. Turkey has seen its official daily death tolls slip back down to under 200 after imposing weekend lockdowns and other daily restrictions in November. Last month, it began requiring passengers arriving from abroad to submit negative PCR tests.
Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Turkey approves China's Sinovac jab, Senegal in talks buy Sinopharm vaccine
Ankara (AFP) Jan 13, 2021
Turkey on Wednesday approved the emergency use of a coronavirus jab developed by China's Sinovac, paving the way for a national vaccination drive that will start with healthcare workers. Health Minister Fahrettin Koca rolled up his sleeve and received the first shot of CoronaVac after announcing plans to start administering it nationally on Thursday. "Everyone should get vaccinated because it is the only way to get rid of this pandemic," Koca said in televised comments. Turkey said last mont ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Tech show offers transport solutions for Covid-changed world

Researchers develop new one-step process for creating self-assembled metamaterials

Researchers acquire 3D images with LED room lighting and a smartphone

Massive US tech show becomes a digital event

EPIDEMICS
The world's first integrated quantum communication network

France signs agreement to purchase Northrop Grumman's E-2D advanced Hawkeye

BlackSky awarded IARPA contract to develop next generation artificial intelligence platform

BAE nabs $4M to demonstrate new radio system for P-8A Poseidon

EPIDEMICS
EPIDEMICS
China sees booming satellite navigation, positioning industry

Galileo satellites help rescue Vendee Globe yachtsman

BeiDou navigation base in south China targets services in ASEAN

GMV wins major contracts for Galileo Second Generation ground segment

EPIDEMICS
U.S. Air Force B-52s travel to Middle East for fourth time since November

Greece gets planes, training and support in $1.68B deal with Israel

Pentagon and Lockheed Martin agree to $1.28B F-35 sustainment contract

Newly-acquired AFRL test aircraft to aid personnel recovery research

EPIDEMICS
The changing paradigm of next-generation semiconductor memory development

Light-based processors boost machine-learning processing

Mollenkopf to step down as CEO of chip giant Qualcomm

A high order for a low dimension

EPIDEMICS
Dust from the deep sea provides clues to future wind patterns

Winds of change: German weather maps to herald nation's diversity

Subscriptions to satellite alerts linked to decreased deforestation in Africa

A new TanSat XCO2 global product for climate studies

EPIDEMICS
From macaques to crabs, wildlife faces threat from face masks

Early pandemic lockdowns had limited impact on urban air pollution

Mexico City plastic ban poses challenge for virus-hit firms

Washing your clothes can create Arctic microplastic pollution









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.